• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱泼斯坦-巴尔病毒编码的潜伏膜蛋白1通过核因子κB信号通路诱导TRAF1表达以促进鼻咽癌的抗凋亡活性。

Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.

作者信息

Wang Chengxing, Ai Midan, Ren Wei, Xiao Hui, Li Xiaoyan, Tang Faqing, Gu Huanhua, Yi Wei, Weng Xinxian, Deng Xiyun, Cao Ya

机构信息

Department of Oral and Maxillofacial Surgery, Xiang Ya Hospital, Central Southern University, Changsha 410078, China.

出版信息

Chin Med J (Engl). 2003 Jul;116(7):1022-8.

PMID:12890376
Abstract

OBJECTIVES

To identify whether Epstein-Barr virus (EBV) encoded latent membrane protein 1 (LMP1) can induce tumor necrosis factor receptor-associated factor 1 (TRAF1) expression and promote its anti-apoptosis activity via the NF-kappaB signaling pathway, and assess that LMP1 suppresses apoptosis in nasopharyngeal carcinoma (NPC).

METHODS

A stable transfected cell line HNE2-LMP1 was established by introducing LMP1 cDNA into HNE2 cells. Transactivation of TRAF1 was determined by luciferase reporter assay, while expression of TRAF1 mRNA was detected by RT-PCR and expression of TRAF1 protein and caspase 3 by Western blot analysis. Apoptosis activity was observed through fluorescence staining.

RESULTS

LMP1 induced TRAF1 expression in NPC cells and caused a decrease in apoptosis. This induction could be blocked by antisense LMP1. Moreover, LMP1-mediated induction of a TRAF1 promoter-driven reporter gene was significantly impaired when the kappaB site kappaB1 or kappaB5 was disrupted, whereas mutation of kappaB3 had only a minor effect on LMP1 dependent up-regulation of the reporter gene.

CONCLUSION

LMP1 induces TRAF1 expression and promotes its anti-apoptosis activity via the NF-kappaB signaling pathway, which may be one of the mechanisms that LMP1 uses to suppress apoptosis in NPC cells.

摘要

目的

确定爱泼斯坦-巴尔病毒(EBV)编码的潜伏膜蛋白1(LMP1)是否能通过核因子κB(NF-κB)信号通路诱导肿瘤坏死因子受体相关因子1(TRAF1)表达并促进其抗凋亡活性,并评估LMP1对鼻咽癌(NPC)细胞凋亡的抑制作用。

方法

将LMP1 cDNA导入HNE2细胞,建立稳定转染细胞系HNE2-LMP1。通过荧光素酶报告基因检测确定TRAF1的反式激活,通过逆转录-聚合酶链反应(RT-PCR)检测TRAF1 mRNA的表达,通过蛋白质免疫印迹分析检测TRAF1蛋白和半胱天冬酶3的表达。通过荧光染色观察细胞凋亡活性。

结果

LMP1诱导NPC细胞中TRAF1表达并导致细胞凋亡减少。反义LMP1可阻断这种诱导作用。此外,当κB位点κB1或κB5被破坏时,LMP1介导的TRAF1启动子驱动的报告基因诱导明显受损,而κB3突变对LMP1依赖的报告基因上调只有轻微影响。

结论

LMP1通过NF-κB信号通路诱导TRAF1表达并促进其抗凋亡活性,这可能是LMP1抑制NPC细胞凋亡的机制之一。

相似文献

1
Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.爱泼斯坦-巴尔病毒编码的潜伏膜蛋白1通过核因子κB信号通路诱导TRAF1表达以促进鼻咽癌的抗凋亡活性。
Chin Med J (Engl). 2003 Jul;116(7):1022-8.
2
[Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].[在鼻咽癌细胞中,基质金属蛋白酶9的表达由爱泼斯坦-巴尔病毒LMP1通过核因子κB或激活蛋白-1信号通路诱导]
Zhonghua Zhong Liu Za Zhi. 2002 Jan;24(1):9-13.
3
[EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma].[EB病毒潜伏膜蛋白1通过核因子κB在鼻咽癌中诱导p53表达]
Zhonghua Zhong Liu Za Zhi. 2001 May;23(3):199-201.
4
Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.爱泼斯坦-巴尔病毒编码的潜伏膜蛋白1(LMP1)和CD40通过涉及肿瘤坏死因子受体相关因子的核因子κB途径介导上皮细胞中白细胞介素-6的产生。
Oncogene. 1997 Jun 19;14(24):2899-916. doi: 10.1038/sj.onc.1201258.
5
Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.爱泼斯坦-巴尔病毒(EBV)潜伏膜蛋白1通过核因子-κB信号通路在EBV感染的鼻咽癌细胞系中诱导白细胞介素-8的产生。
Laryngoscope. 2004 May;114(5):855-9. doi: 10.1097/00005537-200405000-00012.
6
Expression of tumor necrosis factor receptor-associated factor 1 in nasopharyngeal carcinoma: possible upregulation by Epstein-Barr virus latent membrane protein 1.肿瘤坏死因子受体相关因子1在鼻咽癌中的表达:可能受爱泼斯坦-巴尔病毒潜伏膜蛋白1上调
Int J Cancer. 2004 Nov 1;112(2):265-72. doi: 10.1002/ijc.20367.
7
Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.爱泼斯坦-巴尔病毒潜伏膜蛋白1诱导并导致成纤维细胞生长因子-2的释放。
Cancer Res. 2002 Nov 1;62(21):6337-44.
8
Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.爱泼斯坦-巴尔病毒潜伏膜蛋白1(LMP1)上调鼻咽上皮细胞中Id1的表达。
Oncogene. 2004 May 27;23(25):4488-94. doi: 10.1038/sj.onc.1207580.
9
[Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1].[爱泼斯坦-巴尔病毒潜伏膜蛋白1(LMP1)对人鼻咽癌CNE1细胞系凋亡的影响]
Ai Zheng. 2002 May;21(5):498-503.
10
Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells.潜伏膜蛋白1抑制RASSF1A表达,破坏微管结构并诱导人上皮细胞中的染色体畸变。
Oncogene. 2007 May 10;26(21):3069-80. doi: 10.1038/sj.onc.1210106. Epub 2006 Nov 13.

引用本文的文献

1
Comparative genomic study of gastric epithelial cells co-cultured with Helicobacter pylori.与幽门螺杆菌共培养的胃上皮细胞的比较基因组研究。
World J Gastroenterol. 2012 Dec 28;18(48):7212-24. doi: 10.3748/wjg.v18.i48.7212.
2
EBV-encoded LMP1 increases nuclear β-catenin accumulation and its transcriptional activity in nasopharyngeal carcinoma.EB病毒编码的LMP1可增加鼻咽癌中核β-连环蛋白的积累及其转录活性。
Tumour Biol. 2011 Aug;32(4):623-30. doi: 10.1007/s13277-011-0161-x. Epub 2011 Feb 19.
3
Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma.
白细胞介素、层粘连蛋白和 Epstein-Barr 病毒潜伏膜蛋白 1(EBV LMP1)促进鼻咽癌的转移表型。
BMC Cancer. 2010 Oct 22;10:574. doi: 10.1186/1471-2407-10-574.
4
HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.EBV-LMP1介导的HSV-tk/GCV基因疗法用于EBV相关癌症
J Exp Clin Cancer Res. 2008 Sep 23;27(1):42. doi: 10.1186/1756-9966-27-42.